The Blood Club is a bi-weekly informal meeting series of groups from Heidelberg active in research on the hematology and related areas. It is organized by Mick Milsom.

Upcoming Meetings

All meetings take place every second Monday at 16:30 in the ZMBH, Im Neuenheimer Feld 282, in the Seminar Room on the ground floor.


Speaker 1

Speaker 2

September 10, 2018

 *** CANCELLED ***


September 24, 2018

Weike Pei (Rodewald Lab)

Development of the Polylox barcoding system for lineage tracing of hematopoietic stem cells

Sina Stäble (Lipka Lab)

Unidirectional and progressive changes in DNA methylation define hematopoietic lineage commitment

October 8, 2018

Ana-Matea Mikecin (Milsom Lab)

Pia Sommerkamp (Trumpp Lab)
The role of alternative polyadenylation in hematopoiesis

October 22, 2018


Clinical talk: Sascha Dietrich

Drug-perturbation-based stratification of blood cancers

Nikolaus Dietlein (Rodewald Lab)

Towards the role of histone H2B monoubiquitination in the hematopoietic system

October 25, 2018

Guest Seminar

Guest Seminar (DKFZ-ZMBH Alliance)

Speaker: Florian Heidel, Jena University Hospital

Title: Plcg1 maintains leukemia stem cells in t(8;21) AML

Location: ZMBH main seminar room

November 5, 2018

LOCATION: Krehl-Klinik

Patricia Jensen (Scholl/Fröhling Lab)

 *** TBA  ***

November, 12, 2018

SAVE THE DATE: 2nd Retreat of the Heidelberg Leukemia Network – HeLeNe at Internationales Wissenschaftsforum Heidelberg (IWH), Hauptstr. 242, Heidelberg Old-Town

November 19, 2018

LOCATION: Krehl-Klinik

Mariam Hakobyan (Lipka Lab)

*Clinical talk TBA*

December 3, 2018



December 17, 2018iStart at 5pm!

Ruzhica Bogeska (Milsom Lab)

*Clinical talk TBA*



If you want to be included in the Blood-Club Mailing list, This email address is being protected from spambots. You need JavaScript enabled to view it.

Previous Meetings:


Speaker 1

Speaker 2

April 23, 2018

Jagoda Mika (Gröschel Lab)
Functional analysis of the role of retroelements in epigenetic remodelling and transcriptional activation of EVI1 in AML

Elisa Donato (Trumpp Lab)
Mechanistic investigation of epigenetic modifications induced by metabolic changes in AML

May 7, 2018

Shubhankar Sood (Essers Lab)
Inflammation and the bone marrow stem cell niche

Carsten Müller-Tidow*
CXCR4 inhibition to target residual leukemic (stem) cells in AML: The ongoing BLAST trial

June 4, 2018

Pablo Hernandez (Haas Lab)
Hematopoietic Stem Cells, MHC-II and their Interplay with the Adaptive Immune System

Andreas Kulozik (Clinical Talk)
Genetic and epigenetic markers for disease progression in pediatric T-ALL

June 18, 2018

Natasha Anstee (Milsom Lab)
Self renewal of hematopoietic stem cells

Justyna Wierzbinska (Plass Lab / Lipka Lab)
Cell-of-origin and cancer-specific methylome in CLL (chronic lymphocytic leukemia)

July 2, 2018

Mattia Falcone (Trumpp Lab)
BCAT1 restricts aKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

Richard Schlenk (Clinical Talk)
Lessons learned from Gemtuzumab Ozogamicin and Midostaurin approvals and translation into new trial concepts

July 16, 2018

Aykut Demir (Trumpp Lab)
A journey through lineage-specific Myc enhancers in hematopoiesis

Meiqi Ren (Sander Lab)
Deciphering AID dependencies in GC B cell derived lymphomagenesis and progression

July 30, 2018

Xiaomeng Li (Klingmüller Lab)
A systems biology approach to decipher the mechanisms during erythroleukemogenesis

Alwin Krämer (Clinical Talk)

Flt3 inhibition with quizartinib in relapsed/refractory AML